Results of HLA class I typing in 2022

Trials | Specimen | Resolution | HLA-A | No. of labs | HLA-B | No. of labs | HLA-C | No. of labs |
---|---|---|---|---|---|---|---|---|

1st | IHL-22-01 | Generic type | A*01/A*11 | 65 | B*37/B*40 | 65 | C*03/C*06 | 39 |

Allelic type | A*01:01/A*11:01 | 30 | B*37:01/B*40:01 | 30 | C*03:04/C*06:02 | 30 | ||

A*01:01G/A*11:01G | 2 | B*37:01G/B*40:01G | 2 | C*06:02G/C*03:04G | 2 | |||

Serological equivalent | A1/A11 | 65 | B37/B60 | 65 | Cw10/Cw6 | 40 | ||

IHL-22-02 | Generic type | A*02/A*24 | 65 | B*15/B*48 | 65 | C*03/C*04 | 39 | |

Allelic type | A*02:06/A*24:02 | 30 | B*15:01/B*48:01 | 30 | C*03:04/C*04:01 | 28 | ||

A*02:06G/A*24:02G | 2 | B*48:01G/B*15:01G | 2 | C*04:01G/C*03:04G | 2 | |||

Serological equivalent | A2/A24 | 65 | B48/B62 | 65 | Cw10/Cw4 | 40 | ||

2nd | IHL-19-03 | Generic type | A*01/A*02 | 65 | B*54/B*55 | 2 | C*01/Blank | 39 |

B*54/Blank | 63 | |||||||

Allelic type | A*01:01/A*02:01 | 28 | B*54:01/B*54:01 | 3 | C*01:02/C*01:02 | 2 | ||

A*01:01G/A*02:01G | 1 | B*54:01/B*99:99 | 25 | C*01:02/C*99:99 | 25 | |||

B*54:01G/B*99:99 | 1 | |||||||

Serological equivalent | A1/A2 | 65 | B54/Blank | 65 | Cw1/Blank | 40 | ||

IHL-19-04 | Generic type | A*33/Blank | 65 | B*44/Blank | 65 | C*14/Blank | 39 | |

Allelic type | A*33:03/A*33:03 | 3 | B*44:03/B*44:03 | 3 | C*14:03/C*14:03 | 2 | ||

A*33:03/A*99:99 | 26 | B*44:03/B*99:99 | 26 | C*14:03/C*99:99 | 25 | |||

Serological equivalent | A33/Blank | 65 | B44/Blank | 65 | Blank | 25 | ||

Cw1/Blank | 6 | |||||||

Cw14/Blank | 9 |

Abbreviation: HLA, human leukocyte antigen.

Lab Med Qual Assur 2024;46:1~37 https://doi.org/10.15263/jlmqa.2024.46.1.1

© Lab Med Qual Assur

© 2019. Laboratory Medicine and Quality Assurance. / Powered by INFOrang Co., Ltd